As of 2025-11-14, the Relative Valuation of Poolbeg Pharma PLC (POLB.L) is (14.91) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 4.05 GBP, the upside of Poolbeg Pharma PLC based on Relative Valuation is -468.1%.
The range of the Relative Valuation is (15.64) - (15.72) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 20.0x | 14.3x |
| Forward P/E multiples | 19.9x - 27.3x | 23.6x |
| Fair Price | (15.64) - (15.72) | (14.91) |
| Upside | -486.1% - -488.1% | -468.1% |
| Date | P/E |
| 2025-11-07 | -4.73 |
| 2025-11-06 | -4.65 |
| 2025-11-05 | -4.66 |
| 2025-11-04 | -4.80 |
| 2025-11-03 | -4.94 |
| 2025-10-31 | -4.82 |
| 2025-10-30 | -4.84 |
| 2025-10-29 | -4.98 |
| 2025-10-28 | -4.99 |
| 2025-10-27 | -5.00 |
| 2025-10-24 | -4.54 |
| 2025-10-23 | -4.46 |
| 2025-10-22 | -4.47 |
| 2025-10-21 | -4.48 |
| 2025-10-20 | -4.24 |
| 2025-10-17 | -4.60 |
| 2025-10-16 | -4.52 |
| 2025-10-15 | -4.53 |
| 2025-10-14 | -4.48 |
| 2025-10-13 | -4.62 |
| 2025-10-10 | -4.60 |
| 2025-10-09 | -4.52 |
| 2025-10-08 | -4.53 |
| 2025-10-07 | -4.36 |
| 2025-10-06 | -4.37 |
| 2025-10-03 | -4.41 |
| 2025-10-02 | -4.59 |
| 2025-10-01 | -4.60 |
| 2025-09-30 | -4.61 |
| 2025-09-29 | -5.13 |
| 2025-09-26 | -5.04 |
| 2025-09-25 | -4.90 |
| 2025-09-24 | -4.66 |
| 2025-09-23 | -4.93 |
| 2025-09-22 | -5.00 |
| 2025-09-19 | -5.11 |
| 2025-09-18 | -5.03 |
| 2025-09-17 | -5.23 |
| 2025-09-16 | -5.31 |
| 2025-09-15 | -5.64 |
| 2025-09-12 | -5.81 |
| 2025-09-11 | -5.86 |
| 2025-09-10 | -5.87 |
| 2025-09-09 | -5.50 |
| 2025-09-08 | -5.32 |
| 2025-09-05 | -5.07 |
| 2025-09-04 | -5.03 |
| 2025-09-03 | -4.15 |
| 2025-09-02 | -3.98 |
| 2025-09-01 | -4.05 |